BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 20380529)

  • 41. Recurrence of olfactory groove meningiomas.
    Obeid F; Al-Mefty O
    Neurosurgery; 2003 Sep; 53(3):534-42; discussion 542-3. PubMed ID: 12943570
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
    Soni P; Davison MA; Shao J; Momin A; Lopez D; Angelov L; Barnett GH; Lee JH; Mohammadi AM; Kshettry VR; Recinos PF
    J Neurooncol; 2021 Jan; 151(2):173-179. PubMed ID: 33205354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. En plaque sphenoid wing meningiomas: recurrence factors and surgical strategy in a series of 71 patients.
    Mirone G; Chibbaro S; Schiabello L; Tola S; George B
    Neurosurgery; 2009 Dec; 65(6 Suppl):100-8; discussion 108-9. PubMed ID: 19934984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tentorial Meningiomas: Reappraisal of Surgical Approaches and Their Outcomes.
    Nanda A; Patra DP; Savardekar A; Maiti TK; Konar SK; Notarianni C; Guthikonda B; Bir SC
    World Neurosurg; 2018 Feb; 110():e177-e196. PubMed ID: 29097332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection.
    Mooney MA; Abolfotoh M; Bi WL; Tavanaiepour D; Almefty RO; Bassiouni H; Pravdenkova S; Dunn IF; Al-Mefty O
    Neurosurgery; 2020 Oct; 87(5):900-909. PubMed ID: 32294205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time to Recurrence of Intracranial Meningiomas from a Monoinstitutional Surgical Series.
    Maiuri F; Corvino S; Corazzelli G; Berardinelli J; Di Crescenzo RM; Del Basso De Caro M
    World Neurosurg; 2024 May; 185():e612-e619. PubMed ID: 38417623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intracranial angiomatous meningiomas: A 15-year, multicenter study.
    Ben Nsir A; Chabaane M; Krifa H; Jeme H; Hattab N
    Clin Neurol Neurosurg; 2016 Oct; 149():111-7. PubMed ID: 27513979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. WHO grade II and III meningiomas: a study of prognostic factors.
    Durand A; Labrousse F; Jouvet A; Bauchet L; Kalamaridès M; Menei P; Deruty R; Moreau JJ; Fèvre-Montange M; Guyotat J
    J Neurooncol; 2009 Dec; 95(3):367-375. PubMed ID: 19562258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical outcomes after reoperation for recurrent skull base meningiomas.
    Magill ST; Lee DS; Yen AJ; Lucas CG; Raleigh DR; Aghi MK; Theodosopoulos PV; McDermott MW
    J Neurosurg; 2018 May; 130(3):876-883. PubMed ID: 29726777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas.
    Pollock BE; Stafford SL; Utter A; Giannini C; Schreiner SA
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1000-5. PubMed ID: 12605979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiotherapy for atypical meningiomas.
    Mair R; Morris K; Scott I; Carroll TA
    J Neurosurg; 2011 Oct; 115(4):811-9. PubMed ID: 21699480
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is Simpson grade I removal necessary in all cases of spinal meningioma? Assessment of postoperative recurrence during long-term follow-up.
    Tsuda K; Akutsu H; Yamamoto T; Nakai K; Ishikawa E; Matsumura A
    Neurol Med Chir (Tokyo); 2014; 54(11):907-13. PubMed ID: 24759095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short-Term Results of Simpson Grade 2 Resection in Spinal Meningiomas.
    Sarıkaya C; Ramazanoğlu AF; Yaltırık CK; Etli MU; Önen MR; Naderi S
    World Neurosurg; 2023 Mar; 171():e792-e795. PubMed ID: 36587895
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features and treatment of World Health Organization grade II and III meningiomas in childhood: report of 23 cases.
    Wang XQ; Jiang CC; Zhao L; Gong Y; Hu J; Chen H
    J Neurosurg Pediatr; 2012 Nov; 10(5):423-33. PubMed ID: 22938082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Skull base meningiomas: a predictive system to know the extent of their surgical resection and patient outcome].
    Morales F; Maillo A; Díaz-Alvarez A; Merino M; Muñoz-Herrera A; Hernández J; Santamarta D
    Neurocirugia (Astur); 2005 Dec; 16(6):477-85. PubMed ID: 16378129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.
    Park S; Cha YJ; Suh SH; Lee IJ; Lee KS; Hong CK; Kim JW
    J Cancer Res Clin Oncol; 2019 May; 145(5):1351-1360. PubMed ID: 30953136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
    Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
    J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
    Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
    Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors influencing meningioma recurrence rate.
    Naumann M; Meixensberger J
    Acta Neurochir (Wien); 1990; 107(3-4):108-11. PubMed ID: 2077846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.